Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 184328, 12 pages
http://dx.doi.org/10.1155/2010/184328
Review Article

The Battle between Virus and Host: Modulation of Toll-Like Receptor Signaling Pathways by Virus Infection

Department of Microbiology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan

Received 29 November 2009; Accepted 7 April 2010

Academic Editor: Martha Triantafilou

Copyright © 2010 Shin-ichi Yokota et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kawai and S. Akira, “The roles of TLRs, RLRs and NLRs in pathogen recognition,” International Immunology, vol. 21, no. 4, pp. 317–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Takeuchi and S. Akira, “Innate immunity to virus infection,” Immunological Reviews, vol. 227, no. 1, pp. 75–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Takeuchi and S. Akira, “MDA5/RIG-I and virus recognition,” Current Opinion in Immunology, vol. 20, no. 1, pp. 17–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Inohara and G. Nunez, “NODS: intracellular proteins involved in inflammation and apoptosis,” Nature Reviews Immunology, vol. 3, no. 5, pp. 371–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Takaoka, Z. Wang, M. K. Choi et al., “DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response,” Nature, vol. 448, no. 7152, pp. 501–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. L. McGuire, V. E. Curtiss, E. L. Larson, and W. A. Haseltine, “Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression,” Journal of Virology, vol. 67, no. 3, pp. 1590–1599, 1993. View at Google Scholar
  7. F. Bex and R. B. Gaynor, “Regulation of gene expression by HTLV-I tax protein,” Methods, vol. 16, no. 1, pp. 83–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. D. Robek and L. Ratner, “Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone,” Journal of Virology, vol. 73, no. 6, pp. 4856–4865, 1999. View at Google Scholar · View at Scopus
  9. R. Kubota, Y. Furukawa, S. Izumo, K. Usuku, and M. Osame, “Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP),” Blood, vol. 101, no. 8, pp. 3074–3081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Satou, J. Yasunaga, M. Yoshida, and M. Matsuoka, “HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 720–725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. H. H. Baydoun, M. Bellon, and C. Nicot, “HTLV-1 Yin and Yang: rex and p30 master regulators of viral mRNA trafficking,” AIDS Reviews, vol. 10, no. 4, pp. 195–204, 2008. View at Google Scholar · View at Scopus
  12. V. Haehnel, L. Schwarzfischer, M. J. Fenton, and M. Rehli, “Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages,” Journal of Immunology, vol. 168, no. 11, pp. 5629–5637, 2002. View at Google Scholar · View at Scopus
  13. M. Rehli, A. Poltorak, L. Schwarzfischer, S. W. Krause, R. Andreesen, and B. Beutler, “PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene,” Journal of Biological Chemistry, vol. 275, no. 13, pp. 9773–9781, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Datta, U. Sinha-Datta, N. K. Dhillon, S. Buch, and C. Nicot, “The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages,” Journal of Biological Chemistry, vol. 281, no. 33, pp. 23414–23424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Fukumoto, M. Dundr, C. Nicot et al., “Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12I protein of human T-cell leukemia/lymphoma virus type 1,” Journal of Virology, vol. 81, no. 17, pp. 9088–9099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-L. Chiu and W. C. Greene, “APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle,” Journal of Biological Chemistry, vol. 281, no. 13, pp. 8309–8312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Y.-L. Chiu and W. C. Greene, “The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements,” Annual Review of Immunology, vol. 26, pp. 317–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Sheehy, N. C. Gaddis, and M. H. Malim, “The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif,” Nature Medicine, vol. 9, no. 11, pp. 1404–1407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Peng, K. J. Lei, W. Jin, T. Greenwell-Wild, and S. M. Wahl, “Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity,” Journal of Experimental Medicine, vol. 203, no. 1, pp. 41–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Chen, J. Huang, C. Zhang et al., “Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells,” Journal of Virology, vol. 80, no. 15, pp. 7645–7657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Meier, G. Alter, N. Frahm et al., “MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands,” Journal of Virology, vol. 81, no. 15, pp. 8180–8191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Demarchi, M. I. Gutierrez, and M. Giacca, “Human immunodeficiency virus type 1 Tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR,” Journal of Virology, vol. 73, no. 8, pp. 7080–7086, 1999. View at Google Scholar · View at Scopus
  23. P. Roux, C. Alfieri, M. Hrimech, E. A. Cohen, and J. E. Tanner, “Activation of transcription factors NF-κB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression,” Journal of Virology, vol. 74, no. 10, pp. 4658–4665, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bour, C. Perrin, H. Akari, and K. Strebel, “The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB,” Journal of Biological Chemistry, vol. 276, no. 19, pp. 15920–15928, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. S. D. Tachado, J. Zhang, J. Zhu, N. Patel, and H. Koziel, “HIV impairs TNF-α release in response to Toll-like receptor 4 stimulation in human macrophages in vitro,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 6, pp. 610–621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Bandres and L. Ratner, “Human immunodeficiency virus type 1 nef protein down-regulates transcription factors NF-κB and AP-1 in human T cells in vitro after T-cell receptor stimulation,” Journal of Virology, vol. 68, no. 5, pp. 3243–3249, 1994. View at Google Scholar · View at Scopus
  27. A. Boasso, M. Vaccari, J. Nilsson et al., “Do regulatory t-cells play a role in AIDS pathogenesis?” AIDS Reviews, vol. 8, no. 3, pp. 141–147, 2006. View at Google Scholar · View at Scopus
  28. S. Chang, A. Dolganiuc, and G. Szabo, “Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins,” Journal of Leukocyte Biology, vol. 82, no. 3, pp. 479–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Li, E. Foy, J. C. Ferreon et al., “Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 8, pp. 2992–2997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Abe, Y. Kaname, I. Hamamoto et al., “Hepatitis C virus nonstructural protein 5A modulates the Toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines,” Journal of Virology, vol. 81, no. 17, pp. 8953–8966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K.-J. Park, S.-H. Choi, D.-H. Choi et al., “Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2,” Journal of Biological Chemistry, vol. 278, no. 33, pp. 30711–30718, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. L. Yonkers, B. Rodriguez, K. A. Milkovich et al., “TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection,” Journal of Immunology, vol. 178, no. 7, pp. 4436–4444, 2007. View at Google Scholar · View at Scopus
  33. L. Golden-Mason, B. Palmer, J. Klarquist, J. A. Mengshol, N. Castelblanco, and H. R. Rosen, “Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction,” Journal of Virology, vol. 81, no. 17, pp. 9249–9258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Takeda, M. Tahara, T. Hashiguchi et al., “A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism,” Journal of Virology, vol. 81, no. 21, pp. 12091–12096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Takeda, “Measles virus breaks through epithelial cell barriers to achieve transmission,” Journal of Clinical Investigation, vol. 118, no. 7, pp. 2386–2389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Bieback, E. Lien, I. M. Klagge et al., “Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling,” Journal of Virology, vol. 76, no. 17, pp. 8729–8736, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Hahm, J.-H. Cho, and M. B. A. Oldstone, “Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis,” Virology, vol. 358, no. 2, pp. 251–257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L. de Witte, M. Abt, S. Schneider-Schaulies, Y. van Kooyk, and T. B. H. Geijtenbeek, “Measles virus targets DC-SIGN to enhance dendritic cell infection,” Journal of Virology, vol. 80, no. 7, pp. 3477–3486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Schlender, V. Hornung, S. Finke et al., “Inhibition of Toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus,” Journal of Virology, vol. 79, no. 9, pp. 5507–5515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Servet-Delprat, P.-O. Vidalain, H. Bausinger et al., “Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells,” Journal of Immunology, vol. 164, no. 4, pp. 1753–1760, 2000. View at Google Scholar · View at Scopus
  41. T. Indoh, S. Yokota, T. Okabayashi, N. Yokosawa, and N. Fujii, “Suppression of NF-κB and AP-1 activation in monocytic cells persistently infected with measles virus,” Virology, vol. 361, no. 2, pp. 294–303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Yokota, T. Okabayashi, N. Yokosawa, and N. Fujii, “Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20,” FASEB Journal, vol. 22, no. 1, pp. 74–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Fernandez-Sesma, S. Marukian, B. J. Ebersole et al., “Influenza virus evades innate and adaptive immunity via the NS1 protein,” Journal of Virology, vol. 80, no. 13, pp. 6295–6304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. B. G. Hale, R. E. Randall, J. Ortin, and D. Jackson, “The multifunctional NS1 protein of influenza A viruses,” Journal of General Virology, vol. 89, part 10, pp. 2359–2376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. Richt and A. Garcia-Sastre, “Attenuated influenza virus vaccines with modified NS1 proteins,” Current Topics in Microbiology and Immunology, vol. 333, pp. 177–195, 2009. View at Google Scholar
  46. F. P. Polack, P. M. Irusta, S. J. Hoffman et al., “The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8996–9001, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Reimers, K. Buchholz, and H. Werchau, “Respiratory syncytial virus M2-1 protein induces the activation of nuclear factor κB,” Virology, vol. 331, no. 2, pp. 260–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. K. M. Spann, K. C. Tran, and P. L. Collins, “Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-κB, and proinflammatory cytokines,” Journal of Virology, vol. 79, no. 9, pp. 5353–5362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Stack, I. R. Haga, M. Schroder et al., “Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence,” Journal of Experimental Medicine, vol. 201, no. 6, pp. 1007–1018, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Maloney, M. Schroder, and A. G. Bowie, “Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10,” Journal of Biological Chemistry, vol. 280, no. 35, pp. 30838–30844, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. G. DiPerna, J. Stack, A. G. Bowie et al., “Poxvirus protein N1L targets the I-?B kinase complex, inhibits signaling to NF-?B by the tumor necrosis factor superfamily of receptors, and inhibits NF-?B and IRF3 signaling by Toll-like receptors,” Journal of Biological Chemistry, vol. 279, no. 35, pp. 36570–36578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Slezak, K. Guzik, and H. Rokita, “Regulation of interleukin 12 and interleukin 10 expression in vaccinia virus-infected human monocytes and U-937 cell line,” Cytokine, vol. 12, no. 7, pp. 900–908, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. C. Hartman, E. P. Black, and A. Amalfitano, “Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the Toll-like receptor pathway in A549 cells,” Virology, vol. 358, no. 2, pp. 357–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. D. L. Lichtenstein, K. Toth, K. Doronin, A. E. Tollefson, and W. S. M. Wold, “Functions and mechanisms of action of the adenovirus E3 proteins,” International Reviews of Immunology, vol. 23, no. 1-2, pp. 75–111, 2004. View at Google Scholar · View at Scopus
  55. A. L. McNees, C. T. Garnett, and L. R. Gooding, “The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis,” Journal of Virology, vol. 76, no. 19, pp. 9716–9723, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Delgado-Lopez and M. S. Horwitz, “Adenovirus RIDαβ complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression,” Journal of Virology, vol. 80, no. 13, pp. 6378–6386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. K. W. Boehme, M. Guerrero, and T. Compton, “Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells,” Journal of Immunology, vol. 177, no. 10, pp. 7094–7102, 2006. View at Google Scholar · View at Scopus
  58. J. Vomaske, J. A. Nelson, and D. N. Streblow, “Human cytomegalovirus US28: a functionally selective chemokine binding receptor,” Infectious Disorders-Drug Targets, vol. 9, no. 5, pp. 548–556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Eickhoff, M. Hanke, M. Stein-Gerlach et al., “RICK activates a NF-?B-dependent anti-human cytomegalovirus response,” Journal of Biological Chemistry, vol. 279, no. 10, pp. 9642–9652, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. M. A. Jarvis, J. A. Borton, A. M. Keech et al., “Human cytomegalovirus attenuates interleukin-1ß and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-?B activation,” Journal of Virology, vol. 80, no. 11, pp. 5588–5598, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Montag, J. Wagner, I. Gruska, and C. Hagemeier, “Human cytomegalovirus blocks tumor necrosis factor alpha- and interleulkin-1β-mediated NF-κB signaling,” Journal of Virology, vol. 80, no. 23, pp. 11686–11698, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Gaudreault, S. Fiola, M. Olivier, and J. Gosselin, “Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2,” Journal of Virology, vol. 81, no. 15, pp. 8016–8024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. H. J. Martin, M. L. Jae, D. Walls, and S. D. Hayward, “Manipulation of the Toll-like receptor 7 signaling pathway by Epstein-Barr virus,” Journal of Virology, vol. 81, no. 18, pp. 9748–9758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. D. R. Averett, S. P. Fletcher, W. Li, S. E. Webber, and J. R. Appleman, “The pharmacology of endosomal TLR agonists in viral disease,” Biochemical Society Transactions, vol. 35, no. 6, pp. 1468–1472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Makkouk and A. M. Abdelnoor, “The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents,” Immunopharmacology and Immunotoxicology, vol. 31, no. 3, pp. 331–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. P. Schon and M. Schon, “Imiquimod: mode of action,” British Journal of Dermatology, vol. 157, supplement 2, pp. 8–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Gregory, D. Hargett, D. Holmes, E. Money, and S. L. Bachenheimer, “Efficient replication by herpes simplex virus type 1 involves activation of the IκB kinase-IκB-p65 pathway,” Journal of Virology, vol. 78, no. 24, pp. 13582–13590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. M. T. Abreu, P. Vora, E. Faure, L. S. Thomas, E. T. Arnold, and M. Arditi, “Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide,” Journal of Immunology, vol. 167, no. 3, pp. 1609–1616, 2001. View at Google Scholar · View at Scopus
  69. G. Melmed, L. S. Thomas, N. Lee et al., “Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut,” Journal of Immunology, vol. 170, no. 3, pp. 1406–1415, 2003. View at Google Scholar · View at Scopus
  70. H. Kuwata, M. Matsumoto, K. Atarashi et al., “I?BNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation,” Immunity, vol. 24, no. 1, pp. 41–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Carpenter and L. A. J. O'Neill, “How important are Toll-like receptors for antimicrobial responses?” Cellular Microbiology, vol. 9, no. 8, pp. 1891–1901, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. E. A. Misch and T. R. Hawn, “Toll-like receptor polymorphisms and susceptibility to human disease,” Clinical Science, vol. 114, no. 5-6, pp. 347–360, 2008. View at Publisher · View at Google Scholar · View at Scopus